Home » Topics » BioWorld Science

BioWorld Science
RSS

Small-molecule hepcidin production inhibitor developed for treatment of anemia of chronic disease

Nov. 12, 2018

Small-molecule inhibitor of urokinase plasminogen activator ameliorates multiple sclerosis in mice

Nov. 12, 2018

Psoriasis and plaques

Nov. 12, 2018

Inhibiting N-glycase-1 increases the efficacy of chemotherapy in melanoma

Nov. 9, 2018

Chemokine receptor 8 identified as a marker of ANCA-negative ANCA-associated vasculitis

Nov. 9, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

Cue Biopharma and LG Chem collaborate to develop Immuno-STAT biologics for cancer

Nov. 9, 2018

Innovent presents data on sintilimab in first-line squamous NSCLC

Nov. 9, 2018

Palatin reports first-in-human data on subcutaneous dosing with MC1 receptor agonist peptide PL-8177

Nov. 9, 2018

EA Pharma signs joint research agreement to advance E-6011 for Crohn's disease

Nov. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...